Portage Biotech Inc. Files 6-K Report
Ticker: ATON · Form: 6-K · Filed: May 29, 2025 · CIK: 1095435
Sentiment: neutral
Topics: filing, regulatory-update, sec-filing
TL;DR
Portage Biotech filed a 6-K on 5/29/25, incorporating info into its S-8. Standard update.
AI Summary
Portage Biotech Inc. filed a Form 6-K on May 29, 2025, to report on events for the month of May 2025. The filing indicates that this report is incorporated by reference into the company's Form S-8 registration statement (File No. 333-275842). The company is registered under the 1934 Act with SEC file number 001-40086.
Why It Matters
This filing provides an update on the company's activities and incorporates information into its existing registration statements, which can be relevant for investors tracking its regulatory compliance and disclosures.
Risk Assessment
Risk Level: low — This is a routine filing (Form 6-K) that primarily serves to incorporate information into existing registration statements, with no immediate indication of significant new risks.
Key Numbers
- 001-40086 — SEC File Number (Identifies Portage Biotech Inc.'s filing with the SEC.)
- 333-275842 — Form S-8 File Number (This filing is incorporated by reference into this registration statement.)
Key Players & Entities
- Portage Biotech Inc. (company) — Filer of the 6-K report
- 001-40086 (company) — SEC File Number for Portage Biotech Inc.
- 333-275842 (company) — File Number for Portage Biotech Inc.'s Form S-8 registration statement
- 20250529 (date) — Filing date of the Form 6-K
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the issuer makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What does it mean for this 6-K to be incorporated by reference into a Form S-8?
It means that the information contained in this 6-K filing is considered part of Portage Biotech Inc.'s Form S-8 registration statement, which is typically used for employee stock plans.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is May 29, 2025.
What is Portage Biotech Inc.'s SEC file number?
Portage Biotech Inc.'s SEC file number is 001-40086.
Where is Portage Biotech Inc. located?
Portage Biotech Inc.'s principal executive office is located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 29, 2025 regarding PORTAGE BIOTECH INC. (ATON).